category,datetime,headline,id,image,related,source,summary,url
company,1769209306,"Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month",138229923,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock.",https://finnhub.io/api/news?id=aa548706f2b8a7ee330a66dc19a76010ddfc79eb57042f360d304c3b7a9fe401
company,1769191500,Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?,138228445,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.",https://finnhub.io/api/news?id=921ed78dba5a3de16564bf3d9a0f6185fc07cb3cdabc7269749e54bbca782115
company,1769190600,2 Soaring Stocks to Hold for the Next 20 Years,138226926,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,They can power outstanding returns while providing stability to a well-diversified portfolio.,https://finnhub.io/api/news?id=352d8d447636f2f8ced2a104c5de1225b01c835bb039f761185d9fc27ad2b754
company,1769188461,Why Analysts See Merck (MRK) Differently After The Latest Price Target Reset,138226969,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"The latest update to the Merck stock story centers on a revised price target, reflecting how analysts are reassessing the company based on the most recent information available. This shift in expectations highlights how fresh data and evolving views on the business can influence what some see as a reasonable price level for the shares. Stay tuned to see how you can keep on top of these price target changes and the broader narrative around Merck going forward. Analyst Price Targets don't...",https://finnhub.io/api/news?id=e0ada1a41cda9ba3df8956ad02948bbb135499a5aaa890d717433c7dd3b676a1
company,1769175360,Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q4 Earnings,138225631,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"LLY's oncology drugs, led by Verzenio and new launches, are set to support upcoming Q4 results as investor focus broadens beyond GLP-1s.",https://finnhub.io/api/news?id=9b077c59e797e4ea01bcd54334d200de183be16426ec55c70fc8dec1828a99b0
company,1769172009,Wall Street Has a Positive Opinion on Guardant Health (GH),138224805,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"​Guardant Health, Inc. (NASDAQ:GH) is one of the Best Russell 2000 Stocks to Buy Right Now. Wall Street has a positive opinion on Guardant Health, Inc. (NASDAQ:GH). Recently, on January 19, Guardant Health, Inc. (NASDAQ:GH) announced a multi-year partnership with Merck. The collaboration aims to support Merck’s oncology drug development and sales efforts through Guardant’s […]",https://finnhub.io/api/news?id=b5884eb5a6a42a62899cf058e5d2dd7810c2fca2e34a809b00a5bf002e2676fa
company,1769149800,"AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next.",138222072,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers Squibb face similar patent cliffs.",https://finnhub.io/api/news?id=7f99158813c633d0e2153683ce19bb53378d72df1f24fbd52fc9338223c80772
